161 related articles for article (PubMed ID: 35365657)
21. PI3Kγ inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice.
Li H; Park D; Abdul-Muneer PM; Xu B; Wang H; Xing B; Wu D; Li S
Neuroscience; 2013 Dec; 253():89-99. PubMed ID: 24012746
[TBL] [Abstract][Full Text] [Related]
22. Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration.
Ali AY; Wu X; Eissa N; Hou S; Ghia JE; Murooka TT; Banerji V; Johnston JB; Lin F; Gibson SB; Marshall AJ
Leukemia; 2018 Sep; 32(9):1958-1969. PubMed ID: 29479062
[TBL] [Abstract][Full Text] [Related]
23. Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer.
Choi C; Kwon J; Lim S; Helfman DM
Oncotarget; 2016 Sep; 7(39):63466-63487. PubMed ID: 27563827
[TBL] [Abstract][Full Text] [Related]
24. Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection.
Pillinger G; Loughran NV; Piddock RE; Shafat MS; Zaitseva L; Abdul-Aziz A; Lawes MJ; Bowles KM; Rushworth SA
Oncotarget; 2016 Jun; 7(26):39784-39795. PubMed ID: 27174919
[TBL] [Abstract][Full Text] [Related]
25. Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditis.
Silva MC; Davoli-Ferreira M; Medina TS; Sesti-Costa R; Silva GK; Lopes CD; Cardozo LE; Gava FN; Lyroni K; Dias FC; Frade AF; Baron M; Nakaya HI; Figueiredo F; Alves-Filho JC; Cunha FQ; Tsatsanis C; Chevillard C; Cunha-Neto E; Hirsch E; Silva JS; Cunha TM
Nat Commun; 2018 Apr; 9(1):1513. PubMed ID: 29666415
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of phosphoinositide 3-kinase γ attenuates inflammation, obesity, and cardiovascular risk factors.
Wymann MP; Solinas G
Ann N Y Acad Sci; 2013 Mar; 1280():44-7. PubMed ID: 23551103
[TBL] [Abstract][Full Text] [Related]
27. p84 forms a negative regulatory complex with p110γ to control PI3Kγ signalling during cell migration.
Turvey ME; Klingler-Hoffmann M; Hoffmann P; McColl SR
Immunol Cell Biol; 2015 Sep; 93(8):735-43. PubMed ID: 25753393
[TBL] [Abstract][Full Text] [Related]
28. Phosphoinositide 3-kinase gamma controls inflammation-induced myocardial depression via sequential cAMP and iNOS signalling.
Ndongson-Dongmo B; Heller R; Hoyer D; Brodhun M; Bauer M; Winning J; Hirsch E; Wetzker R; Schlattmann P; Bauer R
Cardiovasc Res; 2015 Nov; 108(2):243-53. PubMed ID: 26334033
[TBL] [Abstract][Full Text] [Related]
29. Myosin light chain kinase in microvascular endothelial barrier function.
Shen Q; Rigor RR; Pivetti CD; Wu MH; Yuan SY
Cardiovasc Res; 2010 Jul; 87(2):272-80. PubMed ID: 20479130
[TBL] [Abstract][Full Text] [Related]
30. PI3Kγ within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotes obesity and insulin resistance.
Becattini B; Marone R; Zani F; Arsenijevic D; Seydoux J; Montani JP; Dulloo AG; Thorens B; Preitner F; Wymann MP; Solinas G
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):E854-63. PubMed ID: 21949398
[TBL] [Abstract][Full Text] [Related]
31. p87 and p101 subunits are distinct regulators determining class IB phosphoinositide 3-kinase (PI3K) specificity.
Shymanets A; Prajwal ; Bucher K; Beer-Hammer S; Harteneck C; Nürnberg B
J Biol Chem; 2013 Oct; 288(43):31059-68. PubMed ID: 24014027
[TBL] [Abstract][Full Text] [Related]
32. Myosin light chain kinase and acto-myosin contractility modulate activation of the ERK cascade downstream of oncogenic Ras.
Helfman DM; Pawlak G
J Cell Biochem; 2005 Aug; 95(5):1069-80. PubMed ID: 15962288
[TBL] [Abstract][Full Text] [Related]
33. PI3Kγ/AKT Signaling in High Molecular Weight Hyaluronan (HMWH)-Induced Anti-Hyperalgesia and Reversal of Nociceptor Sensitization.
Bonet IJM; Khomula EV; Araldi D; Green PG; Levine JD
J Neurosci; 2021 Oct; 41(40):8414-8426. PubMed ID: 34417329
[TBL] [Abstract][Full Text] [Related]
34. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
Li M; Sala V; De Santis MC; Cimino J; Cappello P; Pianca N; Di Bona A; Margaria JP; Martini M; Lazzarini E; Pirozzi F; Rossi L; Franco I; Bornbaum J; Heger J; Rohrbach S; Perino A; Tocchetti CG; Lima BHF; Teixeira MM; Porporato PE; Schulz R; Angelini A; Sandri M; Ameri P; Sciarretta S; Lima-Júnior RCP; Mongillo M; Zaglia T; Morello F; Novelli F; Hirsch E; Ghigo A
Circulation; 2018 Aug; 138(7):696-711. PubMed ID: 29348263
[TBL] [Abstract][Full Text] [Related]
35. Molecular determinants of PI3Kγ-mediated activation downstream of G-protein-coupled receptors (GPCRs).
Vadas O; Dbouk HA; Shymanets A; Perisic O; Burke JE; Abi Saab WF; Khalil BD; Harteneck C; Bresnick AR; Nürnberg B; Backer JM; Williams RL
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18862-7. PubMed ID: 24190998
[TBL] [Abstract][Full Text] [Related]
36. PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironment.
Piddock RE; Loughran N; Marlein CR; Robinson SD; Edwards DR; Yu S; Pillinger GE; Zhou Z; Zaitseva L; Auger MJ; Rushworth SA; Bowles KM
Blood Cancer J; 2017 Mar; 7(3):e539. PubMed ID: 28282033
[TBL] [Abstract][Full Text] [Related]
37. Smooth muscle cells-derived CXCL10 prevents endothelial healing through PI3Kγ-dependent T cells response.
Lupieri A; Smirnova NF; Solinhac R; Malet N; Benamar M; Saoudi A; Santos-Zas I; Zeboudj L; Ait-Oufella H; Hirsch E; Ohayon P; Lhermusier T; Carrié D; Arnal JF; Ramel D; Gayral S; Laffargue M
Cardiovasc Res; 2020 Feb; 116(2):438-449. PubMed ID: 31106375
[TBL] [Abstract][Full Text] [Related]
38. PI3Kγ Inhibition Protects Against Diabetic Cardiomyopathy in Mice.
Maffei A; Cifelli G; Carnevale R; Iacobucci R; Pallante F; Fardella V; Fardella S; Hirsch E; Lembo G; Carnevale D
Rev Esp Cardiol (Engl Ed); 2017 Jan; 70(1):16-24. PubMed ID: 27422446
[TBL] [Abstract][Full Text] [Related]
39. Distinct roles of PI3Kδ and PI3Kγ in a toluene diisocyanate-induced murine asthma model.
Xu C; Chen S; Deng Y; Song J; Li J; Chen X; Chang P; Yao L; Tang H
Toxicology; 2021 Apr; 454():152747. PubMed ID: 33711354
[TBL] [Abstract][Full Text] [Related]
40. Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease.
Venable JD; Ameriks MK; Blevitt JM; Thurmond RL; Fung-Leung WP
Recent Pat Inflamm Allergy Drug Discov; 2010 Jan; 4(1):1-15. PubMed ID: 20017720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
